Online Only Articles

Frequent occurrence of non-malignant genetic alterations in clinical grade mesenchymal stromal cells expanded for cell therapy protocols

USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy
USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy
USS Center of Cellular Therapy “G. Lanzani”, A.O. Papa Giovanni XXIII, Bergamo, Italy;USSD Laboratorio di Genetica Medica, A.O. Papa Giovanni XXIII, Bergamo, Italy;USC Hematology, A.O. Papa Giovanni XXIII, Bergamo, Italy
Vol. 99 No. 6 (2014): June, 2014 https://doi.org/10.3324/haematol.2014.104711